Uncategorized

Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.

Tom Spurling – Executive Director – Nova Eye Medical (ASX:EYE) is introducing a comprehensive portfolio of novel glaucoma treatment options which span the entire disease process – enabling physicians to intervene earlier, and more often, in the treatment of glaucoma.

Nicholas Pollock – CEO – K2fly (ASX:K2F) delivers resource governance software and services to Tier 1 clients working in the asset-intensive sectors of mining, utilities, oil and gas, and rail.

Brad Gurrie – CEO – Socialsuite is a global Software-as-a-Service (SaaS) enterprise, leading the industry in offering solutions for Environmental, Social, and Governance reporting and outcomes measurement.

Mark Leong – Executive Chairman – Osteopore (ASX:OSX) is a Singapore-headquartered corporation poised to be a leading medical device company in the region. It is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery use.

Yoav Amitai – CEO – Elsight’s (ASX:ELS) Halo provides connectivity and delivers absolute connection confidence for drones and other unmanned systems.

Dr John Melki – CEO and Director – Genetic Signatures (ASX:GSS) is transforming molecular diagnostics via streamlined sample processing methods linked to highly multiplexed real-time PCR screening assays.

Sam Budiselik – Managing Director – Cash Converters (ASX:CCV) is a diverse group generating revenues from franchising, store operations, personal and vehicle finance.

US interest rates are anticipated to remain elevated for an extended period following the surprising surge in July’s retail sales, which exceeded expectations. The robust 0.7% increase (compared to a forecast of 0.4%) and a revision for June from an initial 0.2% rise to 0.3%, have prompted a couple of US economists to speculate whether

Shares in US banks experienced a drop on Tuesday following indications that the Fitch ratings group might follow rival agency Moody’s in downgrading the credit ratings of several American banks, including industry leader JP Morgan. The news emerged from an interview with a Fitch bank analyst on CNBC, discussing a report released by the ratings